LIPOCINE INC. Proceeds from Other Equity
LIPOCINE INC. (LPCN) reported Proceeds from Other Equity of $5.60 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2020-03-13
- LIPOCINE INC. proceeds from other equity for fiscal 2019 was $5.60M.
- LIPOCINE INC. proceeds from other equity for fiscal 2018 was $0.00.
| Period end | Proceeds from Other Equity 12 month |
|---|---|
| 2019-12-31 | $5.60M 10-K · filed 2020-03-13 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |